|
1
|
Gruss P and Walther C: Pax in development.
Cell. 69:719–722. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goulding MD, Lumsden A and Gruss P:
Signals from the notochord and floor plate regulate the
region-specific expression of two Pax genes in the developing
spinal cord. Development. 117:1001–1016. 1993.PubMed/NCBI
|
|
3
|
Mansouri A, Hallonet M and Gruss P: Pax
genes and their roles in cell differentiation and development. Curr
Opin Cell Biol. 8:851–857. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mansouri A, Goudreau G and Gruss P: Pax
genes and their role in organogenesis. Cancer Res. 59(Suppl):
S1707–S1710. 1999.
|
|
5
|
Poleev A, Fickenscher H, Mundlos S,
Winterpacht A, Zabel B, Fidler A, Gruss P and Plachov D: PAX8, a
human paired box gene: Isolation and expression in developing
thyroid, kidney and Wilms' tumors. Development. 116:611–623.
1992.PubMed/NCBI
|
|
6
|
Kozmik Z, Kurzbauer R, Dörfler P and
Busslinger M: Alternative splicing of Pax-8 gene transcripts is
developmentally regulated and generates isoforms with different
transactivation properties. Mol Cell Biol. 13:6024–6035. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Szczepanek-Parulska E, Szaflarski W,
Piątek K, Budny B, Jaszczyńska-Nowinka K, Biczysko M, Wierzbicki T,
Skrobisz J, Zabel M and Ruchała M: Alternative 3′acceptor site in
the exon 2 of human PAX8 gene resulting in the expression of
unknown mRNA variant found in thyroid hemiagenesis and some types
of cancers. Acta Biochim Pol. 60:573–578. 2013.
|
|
8
|
Miccadei S, Provenzano C, Mojzisek M,
Natali PG and Civitareale D: Retinoblastoma protein acts as Pax 8
transcriptional coactivator. Oncogene. 24:6993–7001. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li CG, Nyman JE, Braithwaite AW and Eccles
MR: PAX8 promotes tumor cell growth by transcriptionally regulating
E2F1 and stabilizing RB protein. Oncogene. 30:4824–4834. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Y-J, Campbell HG, Wiles AK, Eccles
MR, Reddel RR, Braithwaite AW and Royds JA: PAX8 regulates
telomerase reverse transcriptase and telomerase RNA component in
glioma. Cancer Res. 68:5724–5732. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheung HW, Cowley GS, Weir BA, Boehm JS,
Rusin S, Scott JA, East A, Ali LD, Lizotte PH, Wong TC, et al:
Systematic investigation of genetic vulnerabilities across cancer
cell lines reveals lineage-specific dependencies in ovarian cancer.
Proc Natl Acad Sci USA. 108:12372–12377. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Marques AR, Espadinha C, Catarino AL,
Moniz S, Pereira T, Sobrinho LG and Leite V: Expression of
PAX8-PPAR gamma 1 rearrangements in both follicular thyroid
carcinomas and adenomas. J Clin Endocrinol Metab. 87:3947–3952.
2002.PubMed/NCBI
|
|
13
|
French CA, Alexander EK, Cibas ES, Nose V,
Laguette J, Faquin W, Garber J, Moore F Jr, Fletcher JA, Larsen PR,
et al: Genetic and biological subgroups of low-stage follicular
thyroid cancer. Am J Pathol. 162:1053–1060. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dwight T, Thoppe SR, Foukakis T, Lui WO,
Wallin G, Höög A, Frisk T, Larsson C and Zedenius J: Involvement of
the PAX8/peroxisome proliferator-activated receptor gamma
rearrangement in follicular thyroid tumors. J Clin Endocrinol
Metab. 88:4440–4445. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kroll TG, Sarraf P, Pecciarini L, Chen CJ,
Mueller E, Spiegelman BM and Fletcher JA: PAX8-PPARgamma1 fusion
oncogene in human thyroid carcinoma [corrected]. Science.
289:1357–1360. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Laury AR, Perets R, Piao H, Krane JF,
Barletta JA, French C, Chirieac LR, Lis R, Loda M, Hornick JL, et
al: A comprehensive analysis of PAX8 expression in human epithelial
tumors. Am J Surg Pathol. 35:816–826. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ordóñez NG: Value of PAX 8 immunostaining
in tumor diagnosis: A review and update. Adv Anat Pathol.
19:140–151. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nonaka D, Tang Y, Chiriboga L, Rivera M
and Ghossein R: Diagnostic utility of thyroid transcription factors
Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol.
21:192–200. 2008.
|
|
19
|
Scouten WT, Patel A, Terrell R, Burch HB,
Bernet VJ, Tuttle RM and Francis GL: Cytoplasmic localization of
the paired box gene, Pax-8, is found in pediatric thyroid cancer
and may be associated with a greater risk of recurrence. Thyroid.
14:1037–1046. 2004. View Article : Google Scholar
|
|
20
|
Ozcan A, Shen SS, Hamilton C, Anjana K,
Coffey D, Krishnan B and Truong LD: PAX 8 expression in
non-neoplastic tissues, primary tumors, and metastatic tumors: A
comprehensive immuno histochemical study. Mod Pathol. 24:751–764.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tong G-X, Yu WM, Beaubier NT, Weeden EM,
Hamele-Bena D, Mansukhani MM and O'Toole KM: Expression of PAX8 in
normal and neoplastic renal tissues: An immunohistochemical study.
Mod Pathol. 22:1218–1227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Albadine R, Schultz L, Illei P, Ertoy D,
Hicks J, Sharma R, Epstein JI and Netto GJ: PAX8 (+)/p63 (−)
immunostaining pattern in renal collecting duct carcinoma (CDC): A
useful immunoprofile in the differential diagnosis of CDC versus
urothelial carcinoma of upper urinary tract. Am J Surg Pathol.
34:965–969. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mhawech-Fauceglia P, Wang D, Samrao D,
Godoy H, Pejovic T, Liu S and Lele S: Pair-Box (PAX8)
protein-positive expression is associated with poor disease outcome
in women with endometrial cancer. Br J Cancer. 107:370–374. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Wang Y, Li J, Yuan Z, Yuan B,
Zhang T, Cragun JM, Kong B and Zheng W: PAX8: A sensitive and
specific marker to identify cancer cells of ovarian origin for
patients prior to neoadjuvant chemotherapy. J Hematol Oncol.
6:602013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tacha D, Zhou D and Cheng L: Expression of
PAX8 in normal and neoplastic tissues: A comprehensive
immunohistochemical study. Appl Immunohistochem Mol Morphol.
19:293–299. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kenny SL, McBride HA, Jamison J and
McCluggage WG: Mesonephric adenocarcinomas of the uterine cervix
and corpus: HPV-negative neoplasms that are commonly PAX8, CA125,
and HMGA2 positive and that may be immunoreactive with TTF1 and
hepatocyte nuclear factor 1-β. Am J Surg Pathol. 36:799–807. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shukla A, Thomas D and Roh MH: PAX8 and
PAX2 expression in endocervical adenocarcinoma in situ and
high-grade squamous dysplasia. Int J Gynecol Pathol. 32:116–121.
2013. View Article : Google Scholar
|
|
28
|
Ruiz-Llorente S, Carrillo Santa de Pau E,
Sastre-Perona A, Montero-Conde C, Gómez-López G, Fagin JA, Valencia
A, Pisano DG and Santisteban P: Genome-wide analysis of Pax8
binding provides new insights into thyroid functions. BMC Genomics.
13:1472012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
David CJ and Manley JL: Alternative
pre-mRNA splicing regulation in cancer: Pathways and programs
unhinged. Genes Dev. 24:2343–2364. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nonaka D, Chiriboga L and Soslow RA:
Expression of pax8 as a useful marker in distinguishing ovarian
carcinomas from mammary carcinomas. Am J Surg Pathol. 32:1566–1571.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao L, Guo M, Sneige N and Gong Y: Value
of PAX8 and WT1 immunostaining in confirming the ovarian origin of
metastatic carcinoma in serous effusion specimens. Am J Clin
Pathol. 137:304–309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Szczepanek-Parulska E, Szaflarski W,
Piątek K, Budny B, Jaszczyńska-Nowinka K, Biczysko M, Wierzbicki T,
Skrobisz J, Zabel M and Ruchała M: Alternative 3′ acceptor site in
the exon 2 of human PAX8 gene resulting in the expression of
unknown mRNA variant found in thyroid hemiagenesis and some types
of cancers. Acta Biochim Pol. 60:573–578. 2013.
|
|
33
|
Kalnina Z, Zayakin P, Silina K and Linē A:
Alterations of pre-mRNA splicing in cancer. Genes Chromosomes
Cancer. 42:342–357. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ohta M, Inoue H, Cotticelli MG, Kastury K,
Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, et al:
The FHIT gene, spanning the chromosome 3p14.2 fragile site and
renal carcinoma-associated t(3;8) breakpoint, is abnormal in
digestive tract cancers. Cell. 84:587–597. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bednarek AK, Keck-Waggoner CL, Daniel RL,
Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ and Aldaz CM: WWOX,
the FRA16D gene, behaves as a suppressor of tumor growth. Cancer
Res. 61:8068–8073. 2001.PubMed/NCBI
|
|
36
|
Stapleton P, Weith A, Urbánek P, Kozmik Z
and Busslinger M: Chromosomal localization of seven PAX genes and
cloning of a novel family member, PAX-9. Nat Genet. 3:292–298.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Karolchik D, Barber GP, Casper J, Clawson
H, Cline MS, Diekhans M, Dreszer TR, Fujita PA, Guruvadoo L,
Haeussler M, et al: The UCSC Genome Browser database: 2014 update.
Nucleic Acids Res. 42(D1): D764–D770. 2014. View Article : Google Scholar :
|
|
38
|
Hecht F, Ramesh KH and Lockwood DH: A
guide to fragile sites on human chromosomes. Cancer Genet
Cytogenet. 44:37–45. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
IJdo JW, Baldini A, Wells RA, Ward DC and
Reeders ST: FRA2B is distinct from inverted telomere repeat arrays
at 2q13. Genomics. 12:833–835. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cheung L, Messina M, Gill A, Clarkson A,
Learoyd D, Delbridge L, Wentworth J, Philips J, Clifton-Bligh R and
Robinson BG: Detection of the PAX8-PPARγ fusion oncogene in both
follicular thyroid carcinomas and adenomas. J Clin Endocrinol
Metab. 88:354–357. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Solinas-Toldo S, Dürst M and Lichter P:
Specific chromosomal imbalances in human papillomavirus-transfected
cells during progression toward immortality. Proc Natl Acad Sci
USA. 94:3854–3859. 1997. View Article : Google Scholar : PubMed/NCBI
|
